Ledger.Open graph →
SEC Form D · filed August 25, 2017

Rapamycin Holdings, Inc

Offering
$3.5M
Sold
Exemption
Rule 506(c)
Industry
Pharmaceuticals
Location
SAN ANTONIO, TX
Type

Rule 506(c): private placement that may advertise publicly; all investors must be verified accredited.

People & firms on this filing (4)

Thomas T. Mcpherson · Phoenix, AZExecJanet L. Mcwilliams · Chicago, ILExecStevens Asset Management LLC · DARIEN, CTDirectorSapna S. Srivastava · Baltimore, MDExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗